Five Types of Heart Failure Identified Using AI Tools

Five subtypes of heart failure that could potentially be used to predict future risk for individual patients have been identified in a new study led by UCL researchers.

Heart failure is an umbrella term for when the heart is unable to pump blood around the body properly. Current ways of classifying heart failure do not accurately predict how the disease is likely to progress.

For the study, published in Lancet Digital Health, researchers looked at detailed anonymised patient data from more than 300,000 people aged 30 years or older who were diagnosed with heart failure in the UK over a span of 20 years. Using several machine learning methods, they identified five subtypes: early onset, late onset, atrial fibrillation related (atrial fibrillation is a condition causing an irregular heart rhythm), metabolic (linked to obesity but with a low rate of cardiovascular disease), and cardiometabolic (linked to obesity and cardiovascular disease).

The researchers found differences between the subtypes in patients’ risk of dying in the year after diagnosis. The all-cause mortality risks at one year were: early onset (20%), late onset (46%), atrial fibrillation related (61%), metabolic (11%), and cardiometabolic (37%).

The research team also developed an app that clinicians could potentially use to determine which subtype a person with heart failure has, which may potentially improve predictions of future risk and inform discussions with patients.

Lead author Professor Amitava Banerjee (UCL Institute of Health Informatics) said: "We sought to improve how we classify heart failure, with the aim of better understanding the likely course of disease and communicating this to patients. Currently, how the disease progresses is hard to predict for individual patients. Some people will be stable for many years, while others get worse quickly.

"Better distinctions between types of heart failure may also lead to more targeted treatments and may help us to think in a different way about potential therapies.

"In this new study, we identified five robust subtypes using multiple machine learning methods and multiple datasets.

"The next step is to see if this way of classifying heart failure can make a practical difference to patients - whether it improves predictions of risk and the quality of information clinicians provide, and whether it changes patients' treatment. We also need to know if it would be cost effective. The app we have designed needs to be evaluated in a clinical trial or further research, but could help in routine care."

To avoid bias from a single machine learning method, the researchers used four separate methods to group cases of heart failure. They applied these methods to data from two large UK primary care datasets, which were representative of the UK population as a whole and were also linked to hospital admissions and death records. (The datasets were Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN), covering the years 1998 to 2018.)

The research team trained the machine learning tools on segments of the data and, once they had selected the most robust subtypes, they validated these groupings using a separate dataset.

The subtypes were established on the basis of 87 (of a possible 635) factors including age, symptoms, the presence of other conditions, the medications the patient was taking, and the results of tests (e.g., of blood pressure) and assessments (e.g., of kidney function).

The team also looked at genetic data from 9,573 individuals with heart failure from the UK Biobank study. They found a link between particular subtypes of heart failure and higher polygenic risk scores (scores of overall risk due to genes as a whole) for conditions such as hypertension and atrial fibrillation.

The study was supported by the BigData@Heart Consortium from the European Union Innovative Medicines Initiative-2.

Banerjee A, Dashtban A, Chen S, Pasea L, Thygesen JH, Fatemifar G, Tyl B, Dyszynski T, Asselbergs FW, Lund LH, Lumbers T, Denaxas S, Hemingway H.
Identifying subtypes of heart failure from three electronic health record sources with machine learning: an external, prognostic, and genetic validation study.
Lancet Digit Health. 2023 Jun;5(6):e370-e379. doi: 10.1016/S2589-7500(23)00065-1

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...